Comparison - NARI - NASDAQ

Weiss Ratings	NARI - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Rating	D
Reward Index	Very Weak
Risk Index	Weak
Risk Grade	D
Reward Grade	E

Rating Factors	NARI - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	Weak
Efficiency Index	Very Weak
Solvency Index	Excellent
Total Return Index	Weak
Volatility Index	Weak

Beta / Standard Deviation	NARI - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Beta	0.20

Price History	NARI - NASDAQ	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	--
30-Day Total Return	--
60-Day Total Return	--
90-Day Total Return	--
Year to Date Total Return	--
1-Year Total Return	--
2-Year Total Return	--
3-Year Total Return	--
5-Year Total Return	--
52-Week High % Change	--
52-Week Low % Change	--

Price	NARI - NASDAQ	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$79.99
52-Week Low Price	$36.73
52-Week Low Price (Date)	Apr 22, 2024
52-Week High Price (Date)	Feb 18, 2025

Valuation	NARI - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Market Cap	--
Enterprise Value	4.62B
Price/Earnings (TTM)	--
Earnings Per Share (TTM)	-1.36
Earnings Per Share Growth	--
Price/Earnings To Growth	--
Price/Sales (TTM)	8.12
Price/Book (Q)	10.75
Enterprise Value/Revenue (TTM)	--
Price	--
Enterprise Value/EBITDA (TTM)	--
Enterprise Value/EBIT	--
Market Cap Category	Mid Cap

Dividends and Shares	NARI - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	58.37M
Dividend Yield	--
Div. Per Share (Most Recent)	--
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	--

Company Info	NARI - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Phone Number	877 923 4747
Address	6001 Oak Canyon Irvine, CA 92618
Website	www.inarimedical.com
Country	United States
Year Founded	2011

Profitability	NARI - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	-5.10%
Profit Margin	-13.67%

Management Effectiveness	NARI - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Return on Assets	-2.94%
Return on Equity	--

Income Statement	NARI - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	574.50M
Total Revenue (TTM)	574.50M
Revenue Per Share	--
Gross Profit (TTM)	498.76M
EBITDA (TTM)	-23.45M
EBIT (TTM)	-29.33M
Net Income (TTM)	-78.58M
Net Income Avl. to Common (TTM)	-78.58M
Total Revenue Growth (Q YOY)	21.39%
Earnings Growth (Q YOY)	-680.87%
EPS Diluted (TTM)	-1.36
EPS Diluted Growth (Q YOY)	-729.40%

Balance Sheet	NARI - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	111.54M
Cash Per Share (Q)	$1.91
Total Current Assets (Q)	263.39M
Total Preferred Equity (Q)	--
Total Equity (Q)	434.76M
Current Ratio (Q)	1.770
Book Value Per Share (Q)	$7.44
Total Assets (Q)	697.24M
Total Current Liabilities (Q)	148.78M
Total Debt (Q)	32.72M
Total Liabilities (Q)	262.48M
Total Common Equity (Q)	434.76M

Cash Flow	NARI - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	-60.57M
Cash from Financing (TTM)	-1.76M
Net Change in Cash (TTM)	-47.97M
Levered Free Cash Flow (TTM)	88.28M
Cash from Operations (TTM)	14.18M